menu search

Anixa (anix) falls 25% despite positive breast cancer study data

Anixa Biosciences (ANIX) announces positive top-line data from its phase Ia study evaluating the safety of its breast cancer vaccine. However, the sto...

April 18, 2023, 12:55 pm

Doctors should embrace bitcoin, says cancer surgeon

Royal Adelaide Hospital bowel cancer surgeon Tarik Sammour says doctors should look beyond their tradit...

April 18, 2023, 2:59 am

As a breast cancer survivor, i’ve seen firsthand how early detection and clinical trial initiatives save lives

By: Denise Hyater-Lindenmuth, Executive Director of the National Women’s Health Network Washington D.C., April 14, 2023 (GLOBE NEWSWIRE) — Diagnos...

April 14, 2023, 1:47 pm

Exact sciences schedules first quarter 2023 earnings call

MADISON, Wis. , April 10, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of canc...

April 10, 2023, 6:00 am

Exact sciences leads the way in low-cost cancer screening

Population-based cancer screening is now closer than ever to becoming a reality. EXAS products have a l...

April 6, 2023, 2:30 am

Astrazeneca's (azn) drug combo meets ovarian cancer study goal

Interim data from a late-stage study shows that AstraZeneca's (AZN) cancer drugs, Lynparza and Imfinzi improved progression-free survival in certain p...

April 5, 2023, 1:42 pm

Johnson & johnson shares rise after company proposes baby powder cancer settlement

Wall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer...

April 5, 2023, 10:47 am

Astrazeneca drug combo improves ovarian cancer survival rate

AstraZeneca PLC (LSE:AZN), the Anglo-Swedish pharmaceutical giant, has announced encouraging results from a planned interim analysis of its DUO-O phas...

April 5, 2023, 3:07 am

Carl icahn tells wsj he wants old ceo back at illumina

Illumina Inc. ILMN activist shareholder and billionaire Carl Icahn told The Wall Street Journal he'd like to see the return of ex-CEO Jay Flatley to r...

March 29, 2023, 8:08 am

Mainz biomed to present at sidoti virtual investor conference march 22-23

BERKELEY, Calif. and MAINZ, Germany, March 21, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a mol...

March 21, 2023, 3:01 am

Merck's (mrk) co-formulation therapy fails lung cancer study

Data from a mid-stage study showed that Merck's (MRK) MK-7684A did not improve progression-free survival as a potential treatment for patients with me...

March 17, 2023, 2:31 pm

Qualigen therapeutics to present five posters at the american association for cancer research annual meeting 2023

CARLSBAD, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified li...

March 15, 2023, 9:05 am

Astrazeneca (azn) posts positive data from lung cancer studies

Data from late-stage label expansion studies show that AstraZeneca's (AZN) cancer drugs are effective for treating non-small cell lung cancer indicati...

March 10, 2023, 11:29 am

Sengine precision medicine receives new york state clep approval for paris® test

From a single sample taken from a patient’s tumor, SEngine scientists can discover which drugs or combinations of drugs are most effective in killin...

March 7, 2023, 5:04 pm

Genetic testing market size to hit usd 17.48 billion by 2030 at 10.10% cagr – report by market research future (mrfr)

Genetic Testing Market Size and Trends Analysis By Type (Prescribed Genetic Testing and Direct-to-Consumer Genetic Testing), Method (Molecular Genetic...

February 27, 2023, 2:45 pm

'here we go again': seagen soars as pfizer reportedly mulls a takeover

Pfizer is in early talks to acquire cancer specialist Seagen, according to a report that sent SGEN stoc...

February 27, 2023, 9:52 am

Gilead (gild) reports positive data from urothelial cancer study

Gilead's (GILD) new and updated positive results from a phase II study show Trodelvy's rapid and durable responses for patients across a range of hard...

February 20, 2023, 1:32 pm

Volitionrx says nu.q vet cancer test now available for pre-order at the point-of-care through heska corporation

VolitionRx (NYSE-A:VNRX) has announced its Nu.Q Vet Cancer Test is now available for pre-order to veterinarians at the point-of-care through Heska Co...

February 16, 2023, 8:51 am

Blueprint's (bpmc) cancer study put on partial hold by fda

Blueprint's (BPMC) early- to mid-stage study for the treatment of patients with CDK2-vulnerable cancers put on partial clinical hold by the FDA....

February 13, 2023, 1:33 pm

Pharmadrug unveils plans for first-in-human clinical study with its lead drug candidate pd-001 in esophageal cancer

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) revealed that it intends to pursue a first-in-human study of its lead drug candidate cepharanthine-2HCL (PD-001...

February 13, 2023, 9:11 am


Search within

Pages Search Results: